Core Viewpoint - Di Rui Medical Technology Co., Ltd. has implemented corrective measures in response to the Jilin Securities Regulatory Bureau's order regarding issues related to the recognition of foreign sales order revenues and internal control deficiencies [1][2]. Group 1: Corrective Measures - The company acknowledged that in 2023, it had recognized revenue of 3.693 million yuan and profit of 716,000 yuan for certain foreign sales orders that were not actually cleared for customs and were returned [2]. - A new accounting policy was adopted effective January 1, 2026, which stipulates that for international sales using EXW terms, revenue is recognized on the date of the customs declaration; for FOB and other terms, revenue is recognized on the later of the bill of lading date or customs declaration date [2]. - The corrective action for the revenue recognition issue is overseen by the company's Vice President and CFO, Zhang Xingyan, with a deadline set for no later than the annual shareholders' meeting in 2025 [2]. Group 2: Internal Control Improvements - The company identified incomplete documentation for some foreign sales orders and has established a customer ordering platform to manage the order process from generation to archiving [3]. - A new inspection mechanism has been introduced to check orders that have been shipped but not cleared for customs within two months, with monthly tracking to ensure timely closure [3]. - The corrective actions are led by Vice President Niu Dandan, and the company plans to enhance compliance training and supervision to prevent similar issues in the future [3].

Core Viewpoint - Tianjin Pharmaceutical Industry Co., Ltd. has acknowledged the regulatory issues raised by the Tianjin Securities Regulatory Bureau and has committed to implementing a comprehensive rectification plan to address these concerns and enhance internal controls and compliance awareness [5][15]. Group 1: Meeting and Decision - The 24th meeting of the 9th Board of Directors was held on February 26, 2026, via telecommunication, with all 9 directors participating [1][3]. - The board unanimously approved the rectification report in response to the Tianjin Securities Regulatory Bureau's corrective measures [1][3]. Group 2: Rectification Requirements - The company aims to strictly adhere to relevant regulations, including the "Guidelines for the Governance of Listed Companies" and internal control application guidelines, ensuring thorough investigation and long-term management of identified issues [5][6]. - The rectification goals include resolving issues related to contract management, timely identification of R&D project termination risks, and improving internal control systems [6][15]. Group 3: Main Issues and Rectification Measures - Identified issues include non-standard contract management and delays in recognizing R&D project termination risks, leading to slow recovery of advance payments [7][10]. - Specific rectification measures include revising contract templates to ensure clarity and compliance, enhancing the contract review process, and establishing a risk management mechanism for R&D projects [8][11]. Group 4: Continuous Rectification Plan - The company has developed a continuous rectification plan to reinforce compliance education, enhance internal control systems, and optimize fund management processes [13][14]. - Ongoing training and supervision will be implemented to ensure adherence to regulations and improve governance standards [13][14]. Group 5: Commitment to Rectification - The board and management have expressed a strong commitment to addressing the issues highlighted by the regulatory authority and ensuring that all rectification measures are completed on time and effectively [15].

Core Viewpoint - Watson Bio announced that it received a decision from the Yunnan Securities Regulatory Bureau on December 18, 2025, regarding the non-compliance of its executive compensation decisions for 2023-2024, which were not submitted for review as required [1] Group 1 - The board of directors has taken the issue seriously and established a special team led by Chairman Li Yunchun to implement corrective measures [1] - Corrective actions include revising systems, improving decision-making procedures, organizing training, conducting self-examinations by independent directors, and holding relevant personnel accountable [1] - Most corrective measures are required to be completed before the annual shareholders' meeting in 2025, and the organization of training and accountability has already been completed, with the company issuing an apology regarding the issue [1]

Group 1 - The core point of the news is that ChaoXun Communication (603322.SH) announced the completion of a share reduction plan by its shareholder, Shanghai JiuYi Private Fund Management Co., Ltd., which reduced its holdings by 2,200,000 shares, accounting for 1.3961% of the total share capital [1][2] - The share reduction occurred between November 25, 2025, and January 7, 2026, with a total amount of 98,302,220 yuan, and the shares were sold at prices ranging from 34.89 yuan to 53.57 yuan per share [1] - Following the share reduction, Shanghai JiuYi's holdings decreased from 10,000,000 shares (6.35% of total shares) to 7,800,000 shares (4.9497% of total shares) [2] Group 2 - ChaoXun Communication received a warning from the Guangdong Securities Regulatory Bureau regarding issues in revenue recognition and internal controls, leading to inaccurate financial disclosures [3][4][5] - The company was found to have incorrectly recognized revenue for its customized computing server business and failed to report income accurately due to delays in data entry [4][5] - Internal control deficiencies were identified, including excessive credit limits for customers and inadequate management of accounts receivable, which resulted in legal actions against the company [6] Group 3 - In response to the warning, ChaoXun Communication's board and management have implemented corrective measures, including correcting financial statements and enhancing revenue recognition policies [7] - The company has committed to strengthening internal controls, improving the management of accounts receivable, and ensuring compliance with relevant regulations [7][8] - The board has also taken steps to hold responsible personnel accountable and improve their understanding of compliance requirements [8] Group 4 - On January 6, 2026, ChaoXun Communication announced that its controlling shareholder, Liang Jianhua, signed a share transfer agreement to sell 7,880,000 shares (5.00% of total shares) to Guangzhou Kangqi Asset Management Center at a price of 35.82 yuan per share, totaling 282,261,600 yuan [8][9] - After the transfer, Liang Jianhua's holdings will decrease from 32,285,000 shares (20.48%) to 24,405,000 shares (15.48%), while Guangzhou Kangqi will hold 7,880,000 shares [9] - This transfer will not change the controlling shareholder or actual controller of ChaoXun Communication [9]

Group 1 - The company, Jieli Rigging Co., Ltd., has announced a systematic rectification plan in response to issues identified by the Hebei Securities Regulatory Bureau, including inaccurate impairment provisions for accounts receivable, untimely disclosure of government subsidies, and irregular corporate governance [1][2] - A special rectification team led by the chairman has been established to oversee the implementation of the corrective measures [1] - As of December 23, the company's stock closed at 7.08 yuan per share, reflecting a decline of 1.26% [1] Group 2 - The company has reorganized its financial personnel to review and learn the policies for provisioning bad debts on accounts receivable, ensuring that the aging of accounts receivable is calculated continuously from the revenue recognition point [1] - The company reported a shortfall of 2.1491 million yuan in bad debt provisions for 2023 due to improper calculation of the aging of certain estimated accounts receivable [1] - A board meeting and audit committee will be held by the end of December 2025 to correct accounting errors and make retrospective adjustments to the financial reports for 2023, 2024, and the third quarter of 2025 [1] Group 3 - The company has revised its internal reporting system for significant information as of November 2025, clarifying the obligations, scope, procedures, and confidentiality requirements for internal reporting [2] - The company received a government subsidy of 1.6362 million yuan in April 2024 but disclosed it only in May, indicating a delay in disclosure [2] - The company has completed the re-election of its board of directors, with the new board having established an audit committee composed of five members, all of whom are independent and have not held senior management positions within the company [2]

Core Viewpoint - The company, Marubi Group, has received an administrative regulatory decision from the Guangdong Securities Regulatory Commission, requiring rectification regarding issues of financial accounting irregularities and management of raised funds [1] Group 1: Financial Rectification - The company has conducted a comprehensive review and self-examination, leading to the approval of a rectification report on November 28 [1] - To address financial accounting irregularities, the company has corrected accounting errors, improved multiple systems, and enhanced training and audit supervision [1] Group 2: Fund Management - In response to issues related to the management of raised funds, the company has organized training to reinforce understanding of regulations and key process points [1] - The rectification has been completed, and the company has taken serious action against responsible individuals, committing to continuous compliance and improvement of governance standards [1]

Core Points - The audit committee of Shenzhen Baoying Construction Holding Group Co., Ltd. has completed the review of the rectification report regarding administrative regulatory measures from the Shenzhen Securities Regulatory Bureau [1] - The rectification report submitted by the company was deemed compliant and the measures were recognized as practical [1] - The audit committee emphasized the importance of adhering to legal regulations and the requirements outlined in the decision document during the review process [1] Summary by Categories - **Regulatory Compliance** - The company received a decision from the Shenzhen Securities Regulatory Bureau on October 17, 2025, which mandated corrective actions and issued warning letters to specific individuals [1] - The audit committee confirmed that the rectification report aligns with legal and regulatory requirements [1] - **Operational Improvements** - The committee plans to enhance the management of key areas such as engineering, procurement, and financial management [1] - There is a commitment to improve the quality of information disclosure to protect the rights of the company and its shareholders [1] - **Future Oversight** - The audit committee will strictly fulfill its supervisory responsibilities to ensure the long-term implementation of the rectification plan [1]

Core Viewpoint - The company has received a corrective order from the Anhui Securities Regulatory Bureau and is implementing a series of measures to enhance its operational compliance and internal controls [1] Group 1: Regulatory Response - On September 23, 2025, the company received a corrective order from the Anhui Securities Regulatory Bureau [1] - A board meeting was held on October 22 to review and approve the corrective report [1] Group 2: Remedial Actions - The company is reassessing the role permissions of its ERP system and supplementing original vouchers [1] - Regular checks of accounting vouchers will be conducted to ensure compliance [1] Group 3: Internal Control Improvements - The company is adjusting its organizational structure and enhancing subsidiary management systems [1] - The compensation system is being refined, and procurement procedures are being supplemented [1] - Expense reimbursement procedures are being streamlined, with regular internal control checks and training planned [1] Group 4: Long-term Commitment - The corrective measures will be ongoing to improve the company's operational standards [1]

Core Viewpoint - The recent announcement from *ST Chuangxing regarding the chairman's detention has significantly impacted the company's reputation and investor confidence, despite claims that the investigation is unrelated to the company [1][3]. Financial Performance - In 2024, *ST Chuangxing reported total revenue of 84.01 million yuan, a year-on-year decline of 35.53%, with a net loss of 193 million yuan, a staggering drop of 814.99% [2]. - For Q1 2025, the company’s revenue plummeted to 24,770 yuan, a 97.83% decrease year-on-year, with a net loss of 5.29 million yuan, down 311.83% [2]. - The half-year performance forecast for 2025 indicates an expected net loss widening to between 12.5 million and 15.5 million yuan, with a non-recurring net loss projected between 13 million and 16 million yuan [2]. Governance and Compliance Issues - The company has a history of regulatory violations, including the investigation of former actual controller Yu Zengyun for suspected fundraising fraud, leading to the judicial freeze of 102 million shares held by the controlling shareholder [2]. - Previous internal control deficiencies resulted in financial reporting errors, prompting warnings from the Shanghai Securities Regulatory Bureau and the Shanghai Stock Exchange [2]. Management Response - Following the chairman's detention, the company appointed Yang Zhe to act as chairman and legal representative, while the management team continues daily operations [1]. - To restore investor confidence, the company must transparently disclose details regarding the chairman's situation, enhance internal governance, and focus on core business operations to improve performance [3].

Group 1 - The company held its second board meeting of the seventh session on July 25, 2025, with all seven directors present, complying with relevant laws and regulations [2] - The board approved the proposal for correcting prior accounting errors and retrospective adjustments with unanimous support [3] - The board emphasized that the corrections align with accounting standards and improve the quality of financial information disclosure [3][4] Group 2 - The supervisory board also convened on July 25, 2025, with all three supervisors present, meeting legal requirements [7] - The supervisory board approved the same proposals regarding accounting error corrections and the rectification report from the Guangxi Securities Regulatory Bureau [8] - The supervisory board will monitor the implementation of corrective measures to enhance the company's operational standards and financial management [9] Group 3 - The company received a directive from the Guangxi Securities Regulatory Bureau on July 4, 2025, requiring corrective actions within 30 days [23] - The company acknowledged issues found during inspections and has actively worked on rectifying management and internal control weaknesses [24] - The company will continue to enhance governance and compliance to prevent similar issues in the future [29] Group 4 - The company reported specific financial adjustments due to prior accounting errors, including reductions in revenue and costs for the years 2021 to 2024 [12][14] - The adjustments will not affect the total assets, liabilities, net assets, net profit, or cash flow of the company [13][15] - The company expressed regret for any inconvenience caused to investors and committed to improving governance and operational standards [20]